Trial Details

COMPLETED
Basic Information
Clinical ID c545
Identifier NCT06446219
Trial Title Efficacy and Safety Comparison of Upadacitinib and Vedolizumab in Second-line Treatment for Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Crohn Disease
Interventions -
Participant Information
Sponsor Sixth Affiliated Hospital, Sun Yat-sen University
City Guangdong
Country/Region China
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2020-01-01
Primary Completion Date 2024-03-31
Completion Date 2024-03-31